12.3.2015   

EN

Official Journal of the European Union

L 67/4

(1)

Pursuant to Article 8(2) of Regulation (EC) No 1925/2006, a Member State may request the Commission to initiate a procedure to include a substance or an ingredient containing a substance other than a vitamin or a mineral in Annex III to Regulation (EC) No 1925/2006 listing the substances whose use in foods is prohibited, restricted or under Union scrutiny, if that substance is associated with a potential risk to consumers as defined by Article 8(1) of Regulation (EC) No 1925/2006.

(2)

On 7 September 2009, Germany sent a request to the Commission regarding the possible harmful effects associated with the intake of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) and Ephedra species and their preparations, and asked the Commission to initiate the procedure under Article 8 of Regulation (EC) No 1925/2006 for those two substances.

(3)

The request by Germany fulfilled the necessary conditions and requirements laid down in Articles 3 and 4 of Commission Implementing Regulation (EU) No 307/2012 (2).

(4)

On 9 September 2011, the Commission asked the European Food Safety Authority (hereafter ‘the Authority’) to evaluate the safety in use of Ephedra and Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) species in food.

(5)

On 3 July 2013, the Authority adopted a scientific opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) (3). It concluded that the chemical and toxicological characterisation of yohimbe bark and its preparations used in food originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) are not adequate to conclude on their safety as ingredients of food. Therefore, it was not possible for the Authority to provide advice on a daily intake of yohimbe bark and its preparations that does not give rise to concerns for human health.

(6)

On 6 November 2013, the Authority adopted a scientific opinion on the safety evaluation of Ephedra species for use in food (4). It found that although the marketing of foods containing Ephedra herb and its preparations in retail outlets is not documented in Europe, food supplements containing Ephedra herbs or their preparations that are typically used for weight loss and athletic performance can easily be purchased via the internet. The Authority concluded that it cannot be excluded that consumers may purchase herbal tea from Ephedra herb via the internet. Given that Ephedra herb and its preparations are marketed almost exclusively as food supplements, the Authority calculated potential exposure levels to the herb from food supplements. It concluded that Ephedra herb and its preparations in food supplements may result in exposure to total ephedra alkaloids or ephedrine which falls within or may exceed the therapeutic dose ranges for the individual ephedra alkaloids or ephedrine, in medicinal products.

(7)

The Authority concluded that due to the absence of adequate toxicity data, it could not provide advice on a daily intake of Ephedra herb and its preparations from all foods that does not give rise to concerns for human health. Nevertheless, it concluded that exposure to total ephedra alkaloids or ephedrine in foods, mainly in food supplements could lead to severe adverse effects on the cardiovascular and central nervous systems (such as hypertension and stroke), which may be enhanced in combination with caffeine. Therefore, the use of Ephedra herb and its preparations containing ephedra alkaloids in food is of significant safety concern for human health.

(8)

The Commission received no comments from interested parties following publication by the Authority of its opinions on Ephedra species and on Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille).

(9)

As there is a possibility of harmful effects on health associated with the use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) and its preparations in foods, but scientific uncertainty persists, the substance should be placed under Union scrutiny and therefore, should be included in Part C of Annex III to Regulation (EC) No 1925/2006. Consequently, during the period of Union scrutiny and pending a decision on whether to allow the use of the substance or to place it in Part A or B of Annex III to Regulation (EC) No 1925/2006 at the end of the scrutiny period, national provisions regulating the use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) in food should still apply.

(10)

Considering the significant safety concern associated with the use of Ephedra herb and its preparations in foods, in particular with regard to exposure to ephedra alkaloids present in food supplements, and considering that no daily intake of Ephedra herb and its preparations that does not give rise to concerns for human health could be set, the use of that substance in foods should be prohibited. Therefore, Ephedra herb and its preparations should be included in Annex III, Part A of Regulation (EC) No 1925/2006.

(11)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

(1)

in Part A, the following entry is added:

‘Ephedra herb and its preparations originating from Ephedra species’

(2)

in Part C, the following entry is added:

‘Yohimbe bark and its preparations originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)’